Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 91Breast Neoplasms 21Insulin Resistance 18Obesity 14Prostatic Neoplasms 10Pancreatic Neoplasms 8Endometrial Neoplasms 7Neoplasms 6Infertility 6Anovulation 6Neoplasm Metastasis 5Colorectal Neoplasms 5Rectal Neoplasms 4Hyperandrogenism 4Weight Loss 3Squamous Cell Carcinoma of Head and Neck 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lung Neoplasms 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hyperinsulinism 3Head and Neck Neoplasms 3Diabetes Mellitus, Type 2 3Diabetes Mellitus 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Recurrence 2Rare Diseases 2Premature Birth 2Overweight 2Ovarian Neoplasms 2

Interventions

bicalutamide 2Mifepristone 2Corlux 2Waist-Hip Ratio 1Waist Circumference 1Time 1Metformin 1Insulin 1Folic Acid 1Flutamide 1Ethinyl Estradiol 1Cyproterone Acetate 1Cardiovascular Physiological Phenomena 1Body Mass Index 1Body Composition 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hirsutism × Metformin × Clear all
NCT00428311 2007-01-31

Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS

Hospital Universitario Ramon y Cajal

Phase 4 Completed
50 enrolled

Hirsutism, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡